Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19
Obesity prevails worldwide to an increasing effect. For example, up to 42% of American adults are considered obese. Obese individuals are prone to a variety of complications of metabolic disorders including diabetes mellitus, hypertension, cardiovascular disease, and chronic kidney disease. Recent m...
Main Authors: | Collins N. Khwatenge, Marquette Pate, Laura C. Miller, Yongming Sang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.732913/full |
Similar Items
-
Dysregulated Interferon Response Underlying Severe COVID-19
by: LeAnn Lopez, et al.
Published: (2020-12-01) -
Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity
by: William Trim, et al.
Published: (2018-02-01) -
Editorial: Immunometabolism in autoimmune and autoinflammatory disorders
by: Fang Zheng, et al.
Published: (2023-11-01) -
Cancer immunometabolism: advent, challenges, and perspective
by: Qin Dang, et al.
Published: (2024-04-01) -
Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma
by: May G. Akl, et al.
Published: (2023-01-01)